At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 24 enrolled
Drug / intervention
Mucinex®drug
Likely dose
Mucinex® 1200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase I, Open-label, Single-dose, Single Period Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Bi-layer Tablet in Normal Healthy Subjects.
In Brief
A Phase 1 clinical trial evaluating Mucinex® for Healthy Subjects. Completed, enrolled 24 participants.
Detailed Summary
Characterize and assess PK of guaifenesin in Mucinex® 1200 mg ER Bi-Layer Tablet
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Subjects
Countries--
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
Primary CompletionOct 2011
First PostedAug 2018
TodayJul 2026
First PostedAug 16, 2018
Enrollment StartOct 11, 2011
Primary CompletionOct 15, 2011
TodayJul 2, 2026
Enrollment to primary: 4 daysPosted 7.9 years ago
Interventions
Mucinex®drug
Mucinex® 1200 mg ER Bi-Layer tablet